Vaccines and Alzheimer’s Disease. What is the connection?

Vaccines: A Promising Shield Against Alzheimer’s Disease

Gita
June 14, 2024

Recent research suggests that routine vaccinations are associated with a reduced risk of developing Alzheimer’s disease. Previous studies revealed that individuals who received at least one flu shot had a 40% lower chance of developing Alzheimer’s compared to those who had not received any vaccination. The new research findings emphasize the practical and accessible benefits of routine adult vaccines in Alzheimer’s prevention.

In a study published in the Journal of Alzheimer’s Disease, researchers discovered that several vaccines commonly administered to adults are linked to a decreased likelihood of developing Alzheimer’s disease (AD). Scientists from the Neurocognitive Disorders Center at McGovern Medical School in Houston, TX, hypothesize that the immune system might play a crucial role in causing brain cell dysfunction in Alzheimer’s. This study suggests that routine vaccinations broadly impact the immune system, reducing the risk of developing the disease. Specifically, the whooping cough vaccine is tied to a 30% lower risk of Alzheimer’s.

To explore this hypothesis, the researchers conducted a retrospective cohort study involving patients who were dementia-free for two years prior and were at least 65 years old at the start of an eight-year follow-up period. They compared two groups of patients: one group vaccinated against tetanus, diphtheria, and pertussis (Tdap/Td), herpes zoster or shingles (HZ), or pneumococcal infections, and another group that remained unvaccinated, using propensity score matching to ensure group similarity. The findings revealed that individuals who received the Tdap/Td vaccine were 30% less likely to develop Alzheimer’s compared to those who did not receive the vaccine.

Kristofer Harris, co-first author of the study and program manager in the Department of Neurology at McGovern Medical School at UTHealth Houston, emphasized that their team found a decreased risk of Alzheimer’s disease among older adults who received routine vaccinations. The risk of Alzheimer’s disease was reduced by 30% with Tdap/Td vaccination, 25% with shingles vaccination, and 27% with pneumococcal vaccination compared to those who did not receive these vaccinations.

The potential mechanisms behind this protective effect might include vaccines altering the immune system’s response to harmful protein build-up in the brain, enhancing immune cells’ efficiency in clearing these proteins, or improving the immune response to protect nearby healthy brain cells. Moreover, vaccination status may indicate overall self-care in aging individuals, with factors like blood pressure control, dietary habits, exercise, sleep routines, and stress levels influencing the risk of developing Alzheimer’s disease.

For more tips read our blog post – Proven Strategies to Lower Your Risk of Alzheimer’s and Dementia

Decreased exposure to common infections may also lower the risk of cognitive decline. Dr. Marshall L. Nash, medical director for the NeuroStudies subnetwork at the Accel Research Sites Network, noted that Alzheimer’s diagnoses often involve detecting abnormal accumulations of amyloid and tau proteins and neuroinflammatory markers. This study confirms that reduced exposure to common infections known to cause neuroinflammation can decrease the risk of subsequent cognitive impairment. Dr. Nash highlighted ongoing trials aimed at limiting neuroinflammation to slow or reverse cognitive decline leading to Alzheimer’s disease.

Harris emphasized the important role of vaccines in reducing Alzheimer’s disease risk. The study’s findings contribute to Alzheimer’s prevention research and public health, underscoring the significance of vaccination. Dr. David Merrill, a geriatric psychiatrist and director of the Pacific Neuroscience Institute’s Pacific Brain Health Center, noted that these findings align with prior research showing that flu shots lower Alzheimer’s risk. He suggested that vaccines might work through a shared immune-system-mediated mechanism to reduce Alzheimer’s risk.

The University of Texas Health Science Center at Houston discovered that people aged 65 and over who received vaccinations are significantly less likely to develop Alzheimer’s disease. This research highlights the importance of vaccinations in protecting against infectious diseases and dementia, with the findings published in the Journal of Alzheimer’s Disease.

Most people receive routine vaccinations in childhood, but vaccines for serious diseases are equally crucial for older individuals. Vaccines against tetanus, diphtheria, whooping cough, and pneumococcal infections are recommended for children and adults, while shingles vaccines are advised for older adults.

Earlier studies in the same journal showed that individuals who received at least one influenza vaccine were 40% less likely to develop Alzheimer’s compared to unvaccinated people in the same age range. The new data revealed that additional adult vaccines are associated with a reduction in Alzheimer’s risk, suggesting that vaccination impacts the immune system more broadly.

Researchers believe that vaccines may change the immune system’s response to the toxic protein build-up associated with Alzheimer’s, enhance the immune cells’ efficiency in clearing these proteins, or improve the immune response to reduce collateral damage to healthy brain cells. While the evidence is compelling, further studies are needed to measure the precise effectiveness of vaccines in protecting against Alzheimer’s.

Recent studies continue to explore the various mechanisms through which vaccines may offer protection against Alzheimer’s disease. These mechanisms include altering the immune system’s behavior in response to harmful proteins, improving the efficiency of immune cells in clearing these proteins, and reducing inflammation in brain cells.

Moreover, vaccines might contribute to a healthier aging process overall, reflecting a broader approach to self-care that includes maintaining a healthy lifestyle, which is known to lower Alzheimer’s risk. This holistic view of health management highlights how preventive measures like vaccinations can play a significant role in reducing the burden of neurodegenerative diseases.

SOTRU Raw Organic Cacao Powder & Super Greens – Fermented Superfood Blend with Digestive Enzymes, Prebiotic Fiber & Antioxidants – Organic, Non-GMO, Gluten Free, Vegan – Chocolate, 30 Servings, 8.47oz

Dr. David Merrill points out that the reduced risk of Alzheimer’s disease with vaccinations might also be linked to a broader range of health behaviors. Vaccinated individuals are often those who also engage in other preventive health measures, such as regular check-ups, healthy eating, and staying physically active. This comprehensive approach to health can contribute to lower incidences of diseases like Alzheimer’s.

As research continues, the scientific community is optimistic about the potential of vaccines to mitigate Alzheimer’s disease. Studies are underway to explore the effects of COVID-19 vaccines on cognitive decline, with preliminary data suggesting that they might also offer neuroprotective benefits.

The emerging evidence supports the need for public health policies that promote routine vaccinations among older adults, not only for protection against infectious diseases but also for their potential role in reducing Alzheimer’s disease risk.

The growing body of research underscores the significant potential of routine vaccinations in reducing the risk of Alzheimer’s disease. By enhancing the immune system’s response and reducing neuroinflammation, vaccines may offer a practical and accessible method for Alzheimer’s prevention. The findings suggest that vaccinations not only protect against infectious diseases but also contribute to overall brain health and cognitive function.

As the population ages, integrating routine vaccinations into public health strategies becomes increasingly vital. Encouraging older adults to receive vaccines such as Tdap/Td, shingles, and pneumococcal vaccines could play a crucial role in mitigating the risk of Alzheimer’s, thereby improving the quality of life and reducing the healthcare burden associated with this debilitating disease.

Continued research in this field will further elucidate the mechanisms behind the protective effects of vaccines and may pave the way for new preventive measures. By promoting vaccination and overall health maintenance, we can make significant strides in the fight against Alzheimer’s disease, ensuring healthier aging for future generations.